Skip to main content
. 2022 Apr 11;17(4):e0265487. doi: 10.1371/journal.pone.0265487

Table 5. Chi-square test of the factors associated with mortality in ABM patients.

Variable Total Survived Died COR 95% CI P-value
N = 321 N = 252 N = 69
Age (years) 0.4–1.1 0.076
<5 156 (48.6) 129 (82.7) 27 (17.3) 0.6
≥5 165 (51.4) 123 (74.5) 42 (25.5) 1
Gender 1.3–4.2 0.004
Male 189 (58.9) 138 (73.0) 51 (27.0) 2.3
Female 132 (41.1) 114 (86.4) 18 (13.6) 1
PCV and Hib vaccination 1.4–6.7 0.004
Yes 80 (24.9) 72 (90.0) 8 (10.0) 1
No 241 (75.1) 180 (74.7) 61 (25.3) 3.0
Place of living 0.7–2.2 0.424
Urban 99 (30.8) 75 (75.8) 24 (24.2) 1.3
Rural 222 (69.2) 177 (79.7) 45 (20.3) 1
Vomiting 0.4–1.5 0.464
Yes 261 (81.3) 207 (79.3) 54 (20.7) 0.8
No 60 (18.7) 45 (75.0) 15 (25.0) 1
Headache (N = 295) 0.7–3.7 0.290
Yes 240 (82.4) 195 (81.2) 45 (18.8) 1.5
No 55 (17.6) 48 (87.3) 7 (12.7) 1
Anorexia 0.3–1.1 0.127
Yes 258 (80.4) 207 (80.2) 51 (19.8) 0.6
No 63 (19.6) 45 (71.4) 18 (28.6) 1
Irritability 0.2–0.8 0.005
Yes 72 (22.4) 48 (66.7) 24 (33.3) 1
No 249 (77.6) 204 (81.9) 45 (18.1) 0.4
Neck stiffness 0.5–1.5 0.576
Yes 177 (55.1) 141 (79.7) 36 (20.3) 0.9
No 144 (44.9) 111 (77.1) 33 (22.9) 1
Coma on admission 2.0–6.9 <0.001
Yes 53 (16.5) 30 (56.6) 23 (43.4) 3.7
No 268 (83.5) 222 (82.8) 46 (17.2) 1
Kernig sign 0.7–1.9 0.702
Yes 147 (45.8) 114 (77.6) 33 (22.4) 1.1
No 174 (54.2) 138 (79.3) 36 (20.7) 1
Purpuric/petechial rash 1.5–10.6 0.002
Yes 18 (5.6) 9 (50.0) 9 (50.0) 4.0
No 303 (94.4) 243 (80.2) 60 (19.8) 1
Concurrent infections 0.5–1.5 0.638
Yes 211 (65.7) 164 (77.7) 47 (22.3) 1
No 110 (34.3) 88 (80.0) 22 (20.0) 0.9
Dexamethasone therapy 2.5–8.5 <0.001
Yes 169 (52.6) 152 (89.9) 17 (10.1) 1
No 152 (47.4) 100 (65.8) 52 (34.2) 4.6

COR, Crude odds ratio; CSF, Cerebrospinal Fluid; Hib, Haemophilus influenzae type b; PCV, Pneumococcal Vaccine.